Amarin Corp Plcuk (AMRN) Net Income Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) Net Income Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -45.25%
Dec 31, 2025 -15.25%
Sep 30, 2025 -2.65%
Jun 30, 2025 -39.07%
Mar 31, 2025 5.25%
Dec 31, 2024 -10.24%
Sep 30, 2024 -48.66%
Jun 30, 2024 23.18%
Mar 31, 2024 16.44%
Dec 31, 2023 -15.81%
Sep 30, 2023 4.63%
Jun 30, 2023 12.49%
Mar 31, 2023 7.34%
Dec 31, 2022 68.74%
Sep 30, 2022 13.84%
Jun 30, 2022 -38.69%
Mar 31, 2022 -8.55%
Dec 31, 2021 -21.60%
Sep 30, 2021 3.57%
Jun 30, 2021 20.92%